Skip to Main Content

Paper Details

Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) inhibitors in patients with male breast cancer: A multicenter study.
Breast
5
2022
Author NameAffiliation
Omer AcarManisa Celal Bayar University Faculty of Medicine
  • 1 - 1

Datasets

Release 1.2